NRX Pharmaceuticals, Inc (NRXP)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Stephen H. Willard |
| Employees: | |
| Web site: | nrxpharma.com |
|
1201 ORANGE STREET, SUITE 600, WILMINGTON, DE, 19801
484-254-6134
| |
-
Formally known as:
- NRX PHARMACEUTICALS ORD SHS
| Date | Ratio |
|---|---|
| 2024-04-02 | 1:10 |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
NRX Pharmaceuticals, Inc. develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure.
Please log in first to see chart